ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Anesthesiology

Top Anesthesiology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SYED HUSSAINI MD

Anesthesiology

1,651

$68.5K

200
99 are 65+

38%
patients receiving schedule two controlled substances

Avg: 42%

52%
patients receiving schedule three controlled substances

Avg: 29%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 16%

$41
Average prescription price

Avg: $78

SHWETHA SIMHAN M.D.

Anesthesiology

667

$39.2K

94
54 are 65+

50%
patients receiving schedule two controlled substances

Avg: 42%

29%
patients receiving schedule three controlled substances

Avg: 29%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 16%

$59
Average prescription price

Avg: $78

TIMOTHY STAACKE M.D.

Anesthesiology

2,174

$184K

104
31 are 65+

63%
patients receiving schedule two controlled substances

Avg: 42%

49%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 16%

$85
Average prescription price

Avg: $78

ANIL DOGRA M.D.

Anesthesiology

1,099

$88.7K

133
78 are 65+

57%
patients receiving schedule two controlled substances

Avg: 42%

36%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$81
Average prescription price

Avg: $78

LAURIE KABINS M.D.

Anesthesiology

1,515

$208K

147
70 are 65+

44%
patients receiving schedule two controlled substances

Avg: 42%

24%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 16%

$137
Average prescription price

Avg: $78

GORDON MORTENSEN M.D.

Anesthesiology

2,753

$230K

488
233 are 65+

68%
patients receiving schedule two controlled substances

Avg: 42%

30%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 16%

$83
Average prescription price

Avg: $78

JOHN BRUSKY M.D.

Anesthesiology

2,645

$192K

531
267 are 65+

63%
patients receiving schedule two controlled substances

Avg: 42%

25%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 16%

$73
Average prescription price

Avg: $78

JEFFREY FOLLANSBEE M.D.

Anesthesiology

248

$6,936

30
0 are 65+

53%
patients receiving schedule two controlled substances

Avg: 42%

0%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 16%

$28
Average prescription price

Avg: $78

ADEGBOYEGA LAWAL M.D.

Anesthesiology

2,072

$188K

187
71 are 65+

63%
patients receiving schedule two controlled substances

Avg: 42%

26%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 16%

$91
Average prescription price

Avg: $78

SCOTT ASCHENBRENER M.D.

Anesthesiology

482

$24.8K

126
55 are 65+

40%
patients receiving schedule two controlled substances

Avg: 42%

43%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 16%

$51
Average prescription price

Avg: $78

ALI SADEGHI M.D.

Anesthesiology

1,145

$129K

112
59 are 65+

60%
patients receiving schedule two controlled substances

Avg: 42%

31%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 16%

$113
Average prescription price

Avg: $78

THOMAS KLOOSTERBOER MD

Anesthesiology

197

$7,171

40
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 42%

0%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$36
Average prescription price

Avg: $78

GURKIRPAL SIKKA M.D.

Anesthesiology

471

$18.9K

89
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 42%

0%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 16%

$40
Average prescription price

Avg: $78

DONALD MCDONALD MD

Anesthesiology

370

$22.5K

61
52 are 65+

26%
patients receiving schedule two controlled substances

Avg: 42%

31%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 16%

$61
Average prescription price

Avg: $78

ROBERT ONG M.D.

Anesthesiology

227

$18.1K

43
20 are 65+

42%
patients receiving schedule two controlled substances

Avg: 42%

47%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 16%

$80
Average prescription price

Avg: $78

DANIEL RESOP M.D.

Anesthesiology

157

$5,092

40
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 42%

0%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 16%

$32
Average prescription price

Avg: $78

GANIU EDU M.D

Anesthesiology

997

$32.5K

273
52 are 65+

42%
patients receiving schedule two controlled substances

Avg: 42%

51%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

3%
prescriptions for brand name drugs

Avg: 16%

$33
Average prescription price

Avg: $78

RANDALL NEMEROVSKI MD

Anesthesiology

1,277

$98.7K

140
53 are 65+

49%
patients receiving schedule two controlled substances

Avg: 42%

66%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 16%

$77
Average prescription price

Avg: $78

THOMAS KLEIN D.O.

Anesthesiology

405

$27K

107
71 are 65+

13%
patients receiving schedule two controlled substances

Avg: 42%

11%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 16%

$67
Average prescription price

Avg: $78

NAVTEJ PUREWAL MD

Anesthesiology

733

$27.3K

170
45 are 65+

64%
patients receiving schedule two controlled substances

Avg: 42%

26%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 16%

$37
Average prescription price

Avg: $78

PAUL HOELL M.D.

Anesthesiology

1,783

$187K

175
108 are 65+

42%
patients receiving schedule two controlled substances

Avg: 42%

22%
patients receiving schedule three controlled substances

Avg: 29%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 16%

$105
Average prescription price

Avg: $78

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank